- Stocks
- Healthcare
- NASDAQ: DXCM

Price (delayed)

$94.14

Market cap

$36.51B

P/E Ratio

101.23

Dividend/share

N/A

EPS

$0.93

Enterprise value

$38.63B

DexCom, Inc. is a company that develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters in San Diego, California. Dexcom was founded in

Dexcom's net income has soared by 55% YoY and by 22% from the previous quarter

The EPS has soared by 55% YoY and by 22% QoQ

The quick ratio has declined by 48% year-on-year but it has grown by 23% since the previous quarter

The debt has soared by 60% YoY and by 59% from the previous quarter

The company's equity fell by 7% YoY and by 6% QoQ

What are the main financial stats of DXCM

Market
Valuations
Earnings

Shares outstanding

387.87M

Market cap

$36.51B

Enterprise value

$38.63B

Price to earnings (P/E)

101.23

Price to book (P/B)

17.37

Price to sales (P/S)

11.38

EV/EBIT

79.61

EV/EBITDA

59.79

EV/Sales

12.08

Revenue

$3.2B

EBIT

$485.3M

EBITDA

$646.1M

Free cash flow

$466M

Per share
Balance sheet
Liquidity

EPS

$0.93

Free cash flow per share

$1.21

Book value per share

$5.42

Revenue per share

$8.27

TBVPS

$17.17

Total assets

$6.82B

Total liabilities

$4.72B

Debt

$3.31B

Equity

$2.1B

Working capital

$2.93B

Debt to equity

1.58

Current ratio

2.42

Quick ratio

2.12

Net debt/EBITDA

3.28

Margins
Efficiency
Dividend

EBITDA margin

20.2%

Gross margin

63.9%

Net margin

11.2%

Operating margin

14%

Return on assets

6.3%

Return on equity

17.3%

Return on invested capital

8.9%

Return on capital employed

10.2%

Return on sales

15.2%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Dexcom stock price performed over time

Intraday

0.9%

1 week

9.39%

1 month

-7.61%

1 year

16.89%

YTD

-16.87%

QTD

0.9%

How have Dexcom's revenue and profit performed over time

Revenue

$3.2B

Gross profit

$2.04B

Operating income

$448.2M

Net income

$357.5M

Gross margin

63.9%

Net margin

11.2%

DXCM's operating income has surged by 89% year-on-year and by 13% since the previous quarter

The operating margin has surged by 57% year-on-year and by 7% since the previous quarter

Dexcom's net income has soared by 55% YoY and by 22% from the previous quarter

The net margin has increased by 30% YoY and by 15% from the previous quarter

What is Dexcom's growth rate over time

What is Dexcom stock price valuation

P/E

101.23

P/B

17.37

P/S

11.38

EV/EBIT

79.61

EV/EBITDA

59.79

EV/Sales

12.08

The EPS has soared by 55% YoY and by 22% QoQ

The stock's price to earnings (P/E) is 27% less than its last 4 quarters average of 136.9

DXCM's P/B is 18% below its 5-year quarterly average of 21.0 and 16% below its last 4 quarters average of 20.4

The company's equity fell by 7% YoY and by 6% QoQ

The stock's price to sales (P/S) is 28% less than its 5-year quarterly average of 15.7 and 21% less than its last 4 quarters average of 14.2

Dexcom's revenue has increased by 20% YoY and by 6% from the previous quarter

How efficient is Dexcom business performance

DXCM's return on invested capital has surged by 85% year-on-year and by 16% since the previous quarter

The ROE has soared by 62% year-on-year and by 24% since the previous quarter

The ROS has soared by 62% YoY and by 15% QoQ

Dexcom's ROA has increased by 37% YoY and by 13% from the previous quarter

What is DXCM's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for DXCM.

How did Dexcom financials performed over time

The company's total assets is 44% higher than its total liabilities

The total liabilities has surged by 59% year-on-year and by 44% since the previous quarter

Dexcom's current ratio has decreased by 49% YoY but it has increased by 20% QoQ

The debt is 58% more than the equity

DXCM's debt to equity has soared by 72% YoY and by 70% QoQ

The debt has soared by 60% YoY and by 59% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.